Mindfulness Approaches for Living After Breast Cancer
(HEAL-ABC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the effectiveness of different digital mindfulness programs for younger breast cancer survivors experiencing feelings of depression. Participants will engage in either live sessions over Zoom or an app-based program to determine which method better improves mood and mental well-being. It is ideal for those diagnosed with breast cancer by age 50, who completed their main treatments at least six months ago, and who continue to experience depressive symptoms. As an unphased trial, this study provides a unique opportunity to investigate innovative approaches to enhancing mental well-being.
Do I need to stop my current medications to join the trial?
The trial does not specify whether you need to stop taking your current medications. However, it mentions that participants may still be taking certain adjuvant therapies, so it seems likely that you can continue your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that mindfulness practices are generally easy for participants to handle. Studies have found that Mindful Awareness Practices (MAPs) can positively impact mental health and boost the immune system in younger breast cancer survivors, offering a promising way to enhance overall well-being.
For the Mindfulness (MAPs) Digital App, research has explored digital health tools and found they benefit breast cancer survivors by helping manage stress and improve mental health.
The Mindfulness (MAPs) Live Online approach also appears promising. Studies suggest that online mindfulness programs can enhance mental health and well-being in cancer patients, proving both practical and effective.
Overall, mindfulness interventions like these are considered safe, with no significant negative effects reported in the studies reviewed. They offer a good option for those looking to support their mental health after breast cancer treatment.12345Why are researchers excited about this trial?
Researchers are excited about the Mindfulness Approaches for Living After Breast Cancer because it introduces innovative ways to support survivors through mindfulness, a method that can complement existing treatments like medication and therapy. The MAPs Live Online offers interactive, live sessions that foster community and personal growth, which is different from traditional solitary meditation practices. Meanwhile, the MAPs Digital App makes mindfulness accessible on-the-go, allowing users to integrate short, impactful sessions into their daily routines. These approaches offer flexibility and personalization, potentially enhancing emotional well-being and quality of life for breast cancer survivors in ways that standard treatments might not fully address.
What evidence suggests that these mindfulness approaches could be effective for breast cancer survivors?
Research has shown that online mindfulness programs can reduce anxiety and improve well-being in breast cancer survivors. In this trial, participants will engage in different mindfulness approaches. The Mindful Awareness Practices (MAPs) Live Online sessions have successfully lowered depression and enhanced both physical and mental health. Another group will use the MAPs Digital App, which studies indicate can lead to better mental health outcomes. These approaches hold promise for helping breast cancer survivors manage their mental health after treatment.12678
Are You a Good Fit for This Trial?
This trial is for female breast cancer survivors who were diagnosed at or before age 50, have finished primary treatment between 6 months and 5 years ago, and are experiencing some depression. They must score within a specific range on a depression questionnaire, be able to use digital devices, understand English or Spanish, and consent to participate in a mindfulness program.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in mindfulness-based interventions either through live online sessions or a digital app over a 6-week period
Post-intervention Assessment
Participants' depressive symptoms are assessed using the CES-D score 2 weeks after the intervention
Follow-up
Participants are monitored for depressive and fatigue symptoms over time
What Are the Treatments Tested in This Trial?
Interventions
- Mindfulness (MAPs) Digital App
- Mindfulness (MAPs) Live Online
Find a Clinic Near You
Who Is Running the Clinical Trial?
NRG Oncology
Lead Sponsor
National Cancer Institute (NCI)
Collaborator